WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 43'3041 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 4'627  4'576  4'523  4'468  4'410  3'804  3'531  3'418 
Births 71  71  71  71  70  57  51  69 
Surviving infants 71  71  71  71  70  57  51  68 
Pop. less than 5 years 363  364  360  351  342  268  280  349 
Pop. less than 15 years 1'000  988  973  954  934  828  954  1'038 
Female 15-49 years 1'159  1'157  1'155  1'152  1'143  994  865  769 

Number of reported case

(Click for retrospective incidence data for Ireland)
Diphtheria
Japanese encephalitis
Measles 107  285  443  164  556  1'106 
Mumps 170  177  308  3'660 
Pertussis 458  229  107  80  803  547 
Polio*
Rubella 10  29  23 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Ireland)
Vaccine year result method % card seen                                                
BCG          80  85  96  95 
DTP1         
DTP3          95  95  94  94  86  65  34 
HepB_BD         
HepB3          95  95  94 
Hib3          95  95  94  93  85 
JapEnc         
MCV          92  92  90  90  79 
MCV2         
PCV1         
PCV3          91  90  88 
Pol3          95  95  94  94  86  81  72 
Rota1         
Rota_last         
Rubella1          92  92  90  90 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Ireland)
BCG 42  42  41  30  30  89  84 
DTP1 98  98  98  98  98  95  85  59 
DTP3 96  95  95  94  94  86  65  34 
HepB3 95  95  95  46 
HepB_BD
Hib3 95  95  95  94  94  85 
MCV 93  92  92  90  90  79  78 
MCV2
PCV3 91  91  90  43 
Pol3 96  95  95  94  94  86  81  72 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; No
DTaPHibHepIPV 2, 4, 6 months; No
DTaPIPV 4-5 years; Yes
HIB 13 months; Yes
HPV 12-13 years; +2, +4 months;
HepB +0, +1, +5 months; Yes Persons with occupational risk of exposure to blood or blood contaminated environments, Family and household contacts, Injecting drug users and their contacts, Individuals at high risk due to medical conditions, Members of other high risk groups
Influenza > 50 years; Yes and persons at risk
MMR 12 months; 4-5 years; Yes Also given to HCW and during outbreaks
MenC_conj 4, 6, 13 months; Yes
Pneumo_conj 2, 6, 12 months; Yes
Pneumo_ps >=65 years; Yes And children >=2 years at risk;
Tdap 11-14 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR     Yes  Yes  NA  Yes   
What years does the MYP cover? number     2011 -2012  2010 -2011    2008-2010   
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR   Yes  Yes  Yes       

System performance

Total Nº districts in country number  
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100%   100  100  100  100  100  13 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100%   25  13   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND     Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR     Yes  Yes    Yes   

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%     100  100    99   

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.